209 related articles for article (PubMed ID: 22689691)
1. Significance of IGFBP-4 in the development of fetal growth restriction.
Qiu Q; Bell M; Lu X; Yan X; Rodger M; Walker M; Wen SW; Bainbridge S; Wang H; Gruslin A
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1429-39. PubMed ID: 22689691
[TBL] [Abstract][Full Text] [Related]
2. Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation.
Giudice LC; Conover CA; Bale L; Faessen GH; Ilg K; Sun I; Imani B; Suen LF; Irwin JC; Christiansen M; Overgaard MT; Oxvig C
J Clin Endocrinol Metab; 2002 May; 87(5):2359-66. PubMed ID: 11994388
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy-associated plasma protein A proteolytic activity is associated with the human placental trophoblast cell membrane.
Sun IY; Overgaard MT; Oxvig C; Giudice LC
J Clin Endocrinol Metab; 2002 Nov; 87(11):5235-40. PubMed ID: 12414897
[TBL] [Abstract][Full Text] [Related]
4. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface.
Han VK; Bassett N; Walton J; Challis JR
J Clin Endocrinol Metab; 1996 Jul; 81(7):2680-93. PubMed ID: 8675597
[TBL] [Abstract][Full Text] [Related]
5. IGFBP-4 and -5 are expressed in first-trimester villi and differentially regulate the migration of HTR-8/SVneo cells.
Crosley EJ; Dunk CE; Beristain AG; Christians JK
Reprod Biol Endocrinol; 2014 Dec; 12():123. PubMed ID: 25475528
[TBL] [Abstract][Full Text] [Related]
6. Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls.
Street ME; Seghini P; Fieni S; Ziveri MA; Volta C; Martorana D; Viani I; Gramellini D; Bernasconi S
Eur J Endocrinol; 2006 Oct; 155(4):567-74. PubMed ID: 16990656
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro.
Byun D; Mohan S; Yoo M; Sexton C; Baylink DJ; Qin X
J Clin Endocrinol Metab; 2001 Feb; 86(2):847-54. PubMed ID: 11158056
[TBL] [Abstract][Full Text] [Related]
8. The regional expression of insulin-like growth factor II (IGF-II) and insulin-like growth factor binding protein-1 (IGFBP-1) in the placentae of women with pre-eclampsia.
Gratton RJ; Asano H; Han VK
Placenta; 2002 Apr; 23(4):303-10. PubMed ID: 11969341
[TBL] [Abstract][Full Text] [Related]
9. [A study on the relationship between insulin-like growth factor, insulin-like growth factor-binding protein-3 and fetal growth retardation].
Zhang P; Liu B; Li G; Wu L; Yu M; Ou Y; Wang L
Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):65-8. PubMed ID: 11953064
[TBL] [Abstract][Full Text] [Related]
10. The pregnancy-associated plasma protein A and insulin-like growth factor system in response to cigarette smoking.
Chelchowska M; Maciejewski T; Gajewska J; Ambroszkiewicz J; Laskowska-Klita T; Leibschang J
J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2377-80. PubMed ID: 22630333
[TBL] [Abstract][Full Text] [Related]
11. Altered placental structure induced by maternal food restriction in guinea pigs: a role for circulating IGF-II and IGFBP-2 in the mother?
Roberts CT; Sohlstrom A; Kind KL; Grant PA; Earl RA; Robinson JS; Khong TY; Owens PC; Owens JA
Placenta; 2001 Apr; 22 Suppl A():S77-82. PubMed ID: 11312635
[TBL] [Abstract][Full Text] [Related]
12. Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks' gestation.
Whitehead CL; McNamara H; Walker SP; Alexiadis M; Fuller PJ; Vickers DK; Hannan NJ; Hastie R; Tuohey L; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Apr; 214(4):521.e1-521.e8. PubMed ID: 26880734
[TBL] [Abstract][Full Text] [Related]
13. The IGF system in the neonatal ovine uterus.
Hayashi K; Carpenter KD; Welsh TH; Burghardt RC; Spicer LJ; Spencer TE
Reproduction; 2005 Mar; 129(3):337-47. PubMed ID: 15749960
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of IGFs and IGF-binding proteins during intrauterine growth restriction in guinea pigs.
Carter AM; Kingston MJ; Han KK; Mazzuca DM; Nygard K; Han VK
J Endocrinol; 2005 Jan; 184(1):179-89. PubMed ID: 15642794
[TBL] [Abstract][Full Text] [Related]
15. The maternal insulin-like growth factor (IGF) and IGF-binding protein response to trisomic pregnancy during the first trimester: a possible diagnostic tool for trisomy 18 pregnancies.
Miell JP; Langford KS; Jones JS; Noble P; Westwood M; White A; Nicolaides KH
J Clin Endocrinol Metab; 1997 Jan; 82(1):287-92. PubMed ID: 8989275
[TBL] [Abstract][Full Text] [Related]
16. The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors.
Reece EA; Wiznitzer A; Le E; Homko CJ; Behrman H; Spencer EM
Obstet Gynecol; 1994 Jul; 84(1):88-95. PubMed ID: 7516515
[TBL] [Abstract][Full Text] [Related]
17. Placental proteases PAPP-A and PAPP-A2, the binding proteins they cleave (IGFBP-4 and -5), and IGF-I and IGF-II: Levels in umbilical cord blood and associations with birth weight and length.
DiPrisco B; Kumar A; Kalra B; Savjani GV; Michael Z; Farr O; Papathanasiou AE; Christou H; Mantzoros C
Metabolism; 2019 Nov; 100():153959. PubMed ID: 31401027
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor (IGF)-II inhibition of endometrial stromal cell tissue inhibitor of metalloproteinase-3 and IGF-binding protein-1 suggests paracrine interactions at the decidua:trophoblast interface during human implantation.
Irwin JC; Suen LF; Faessen GH; Popovici RM; Giudice LC
J Clin Endocrinol Metab; 2001 May; 86(5):2060-4. PubMed ID: 11344207
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts.
Ortiz CO; Chen BK; Bale LK; Overgaard MT; Oxvig C; Conover CA
J Bone Miner Res; 2003 Jun; 18(6):1066-72. PubMed ID: 12817760
[TBL] [Abstract][Full Text] [Related]
20. Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction.
Abu Shehab M; Damerill I; Shen T; Rosario FJ; Nijland M; Nathanielsz PW; Kamat A; Jansson T; Gupta MB
Endocrinology; 2014 Apr; 155(4):1327-39. PubMed ID: 24437487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
